Vascular Effects of Eplerenone in Coronary Artery Disease With Preserved Ejection Fraction: A Double‐Blind, Randomized, Placebo‐Controlled Trial

BACKGROUND: Mineralocorticoid receptor antagonists (MRAs) reduce morbidity and mortality in heart failure with reduced ejection fraction (HFrEF). Their role in patients without heart failure, particularly in patients with coronary artery disease (CAD) and preserved EF, is still a matter of debate. H...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Clin Cardiol
Main Authors: Sudano, Isabella, Naegele, Matthias, Roas, Susanne, Périat, Daniel, Frank, Michelle, Kouroedov, Alexey, Noll, Georg, Lüscher, Thomas F., Enseleit, Frank, Ruschitzka, Frank, Flammer, Andreas J.
Format: Artigo
Sprog:Inglês
Udgivet: Wiley Periodicals, Inc. 2016
Fag:
Clinical Investigations
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6490773/
https://ncbi.nlm.nih.gov/pubmed/26991772
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/clc.22528
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker